L. M. Ellis

1.4k total citations
20 papers, 1.1k citations indexed

About

L. M. Ellis is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L. M. Ellis has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L. M. Ellis's work include Angiogenesis and VEGF in Cancer (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). L. M. Ellis is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). L. M. Ellis collaborates with scholars based in United States, Austria and New Zealand. L. M. Ellis's co-authors include Wenbiao Liu, David J. McConkey, Darren W. Davis, Raymond M. Shaheen, Niels Reinmuth, Philip Hurst, S. Lun, Grant W. Montgomery, K. M. Henderson and Saburo Yano and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Cancer.

In The Last Decade

L. M. Ellis

20 papers receiving 1.1k citations

Peers

L. M. Ellis
N. Shand Switzerland
Jean‐Christophe Sabourin France
Michinari Hirata Japan
Yixin Xu China
Maria Grazia Cerrito Italy
Virginia Calvo Spain
Yi Bao China
Lilach Kleinberg Norway
Lin Guo China
Kirsi‐Maria Haapasaari Finland
N. Shand Switzerland
L. M. Ellis
Citations per year, relative to L. M. Ellis L. M. Ellis (= 1×) peers N. Shand

Countries citing papers authored by L. M. Ellis

Since Specialization
Citations

This map shows the geographic impact of L. M. Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. M. Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. M. Ellis more than expected).

Fields of papers citing papers by L. M. Ellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. M. Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. M. Ellis. The network helps show where L. M. Ellis may publish in the future.

Co-authorship network of co-authors of L. M. Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of L. M. Ellis. A scholar is included among the top collaborators of L. M. Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. M. Ellis. L. M. Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winer, Eric P., Laura A. Levit, Ethan Basch, et al.. (2025). Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers. Journal of Clinical Oncology. 43(17). 2017–2023. 2 indexed citations
2.
Bose, Debashish, Lisa J. Zimmerman, Mariaelena Pierobon, et al.. (2011). Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells. British Journal of Cancer. 105(11). 1759–1767. 69 indexed citations
3.
Lieu, Christopher H., Hang Tran, Michael J. Overman, et al.. (2011). The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer.. Journal of Clinical Oncology. 29(15_suppl). 3533–3533. 18 indexed citations
4.
Love, Neil, Carma L. Bylund, L. M. Ellis, et al.. (2009). Adjuvant therapy report card: Patients with stage II/III colon cancer grade their oncologists. Journal of Clinical Oncology. 27(15_suppl). 4045–4045. 1 indexed citations
5.
Crane, Christopher H., Cathy Eng, Barry W. Feig, et al.. (2008). Phase II trial of neoadjuvant bevacizumab (BEV), capecitabine (CAP), and radiotherapy (XRT) for locally advanced rectal cancer. Journal of Clinical Oncology. 26(15_suppl). 4091–4091. 14 indexed citations
6.
Bylund, Carma L., Neal J. Meropol, John L. Marshall, et al.. (2007). How well do we communicate with patients concerning adjuvant systemic therapy? A survey of 150 colorectal cancer survivors. Journal of Clinical Oncology. 25(18_suppl). 4020–4020. 10 indexed citations
7.
Grothey, Axel, et al.. (2005). Perspectives of patients with colorectal cancer (PCRC): A pilot project to determine interests in and understanding of patient education on clinical research. Journal of Clinical Oncology. 23(16_suppl). 3635–3635. 1 indexed citations
8.
Crane, Christopher H., L. M. Ellis, Henry Q. Xiong, et al.. (2003). 980 Preliminary results of a phase I study of rhumab VEGF (bevacizumab) with concurrent radiotherapy (XRT) and capecitabine (CAP) in locally advanced pancreatic cancer. European Journal of Cancer Supplements. 1(5). S294–S294. 1 indexed citations
9.
Berman, Russell S., Charles A. Portera, & L. M. Ellis. (2001). Biology of Liver Metastases. Cancer treatment and research. 109. 183–206. 13 indexed citations
10.
Ahmad, Syed A., Wenbiao Liu, Young Do Jung, et al.. (2001). Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. Cancer. 92(5). 1138–1143. 97 indexed citations
11.
Shaheen, Raymond M., William W. Tseng, Darren W. Davis, et al.. (2001). Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms.. PubMed. 61(4). 1464–8. 134 indexed citations
12.
Thames, Howard D., et al.. (2001). 5-FU-based adjuvant chemotherapy given after neoadjuvant chemoradiation and surgery for rectal cancer improves survival only among responders. European Journal of Cancer. 37. S271–S271. 2 indexed citations
13.
Yano, Saburo, Hisashi Shinohara, Roy S. Herbst, et al.. (2000). Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis.. PubMed. 60(17). 4959–67. 166 indexed citations
14.
Mendel, Dirk B., Alexander Laird, Beverly D. Smolich, et al.. (2000). Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent.. PubMed. 15(1). 29–41. 189 indexed citations
15.
Ellis, L. M., et al.. (1999). Markedly Elevated Levels of Vascular Endothelial Growth Factor in Malignant Ascites. Annals of Surgical Oncology. 6(4). 373–378. 208 indexed citations
16.
Brown, T.D., Nora A. Janjan, Barry W. Feig, et al.. (1999). 2122 Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 45(3). 339–339. 3 indexed citations
17.
18.
Liu, Wenbiao & L. M. Ellis. (1998). Regulation of Vascular Endothelial Growth Factor Receptor KDR in vitro by a Soluble Factor in Confluent Endothelial Cells. Pathobiology. 66(5). 247–252. 14 indexed citations
19.
Takahashi, Yoko, L. M. Ellis, Mark R. Wilson, et al.. (1996). Progressive upregulation of metastasis-related genes in human colon cancer cells implanted into the cecum of nude mice.. PubMed. 8(4). 163–9. 17 indexed citations
20.
McNatty, K. P., D. A. Heath, K. M. Henderson, et al.. (1984). Some aspects of thecal and granulosa cell function during follicular development in the bovine ovary. Reproduction. 72(1). 39–53. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Shand Breakdown of academic impact, for papers by Jean‐Christophe Sabourin Breakdown of academic impact, for papers by Michinari Hirata Breakdown of academic impact, for papers by Yixin Xu Breakdown of academic impact, for papers by Maria Grazia Cerrito Breakdown of academic impact, for papers by Virginia Calvo Breakdown of academic impact, for papers by Yi Bao Breakdown of academic impact, for papers by Lilach Kleinberg Breakdown of academic impact, for papers by Lin Guo Breakdown of academic impact, for papers by Kirsi‐Maria Haapasaari
Rankless by CCL
2026